Compass Therapeutics, Inc. — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-49M
Free Cash Flow
$-49M
Investing Cash Flow
$-93M
Financing Cash Flow
$130M
Capex
$25K
Acquisitions
—
Stock-Based Comp
$8M
Debt Repaid
—
D&A
$276K
SBC Allocated Expense
$8M
SBC Unrecognized Cost
$15M